Imagine a care team where lab results, device readings, notes and orders flow to the right person at the right time — without manual chasing, copy‑pasting, or guesswork. That’s the promise of clinical interoperability: not a single new product, but the shortest path from shared data to better, safer care.
Why this matters now
In everyday practice, lack of usable data creates bottlenecks: clinicians spend time hunting for information, patients repeat the same story at each visit, and care coordination frays when systems can’t “talk” to one another. When data is standardized, permissioned and computable, teams can automate routine work, close medication loops, run remote monitoring at scale, and measure outcomes across settings. That’s how you turn data into decisions that actually improve health.
What this article will give you
This piece walks straight through the practical: what clinical interoperability really is (and what it isn’t), the technical building blocks that make it work, the ways it unlocks AI, virtual care and value‑based models, and a realistic roadmap you can act on.
- Clear definitions: the four levels of interoperability and the common standards you’ll meet (FHIR, SMART, LOINC, SNOMED, and friends).
- Use cases with measurable ROI: from closed‑loop medication safety to ambient documentation and RPM that reduces admissions.
- Actionable roadmap: 90‑day pilots to 12‑month milestones, plus what to include in procurement and testing so solutions last.
No buzzwords, no vendor fluff — just a practical guide to help clinicians, IT leaders and product teams move from fragmented feeds to reliable, shared data that actually improves care. Keep reading to see how to get there, faster and with less risk than you might think.
What clinical interoperability means today (and what it isn’t)
The four levels: foundational, structural, semantic, organizational
Interoperability is often shortened to “making systems talk,” but real clinical interoperability is layered. Foundational interoperability is the basic ability to connect systems and move data between them. Structural interoperability adds consistent formats and message models so receiving systems can parse and reliably extract fields. Semantic interoperability is the hardest and most valuable layer: it ensures that the meaning of data is shared — that a lab test, allergy, or medication carries the same clinical concept across systems. Finally, organizational interoperability covers the people, policy, workflow, and trust arrangements (consent, roles, responsibilities, contracts) that let data be used safely and legally.
Put simply: connectivity is necessary but not sufficient. Exchanging bytes or PDF reports is not the same as sharing computable, actionable clinical data that teams and downstream services can use without manual re‑interpretation.
The building blocks: HL7 v2/CDA, FHIR R4/R5, SMART on FHIR, CDS Hooks
Standards are the plumbing and language of interoperability. Older but widespread formats such as HL7 v2 and CDA power many point‑to‑point interfaces and document exchanges; their ubiquity matters for compatibility. FHIR (resource‑oriented APIs) is the modern default for exchange and is designed around web APIs, JSON/XML, and well‑defined clinical resources — enabling more flexible, granular, and realtime interactions. SMART on FHIR provides the app model, authentication and launch patterns that let third‑party apps run safely against an EHR. CDS Hooks and similar extension points allow clinical decision support to be invoked at the right workflow moments. Together, these building blocks enable both read and write interactions, app ecosystems, and event‑driven integrations when implemented thoughtfully.
Vocabularies that make data computable: LOINC, SNOMED CT, RxNorm, ICD-10, DICOM, IEEE 11073, IHE profiles
Standards for transport do not guarantee shared meaning — controlled vocabularies do. Vocabularies and code systems translate clinical concepts into machine‑interpretable tokens: laboratory tests and results, clinical findings, medications, diagnoses, imaging studies, and device metrics. When implementers map data to established terminologies, downstream systems can interpret values consistently, enable decision support, aggregate measures, and feed analytics and quality programs without fragile ad‑hoc mappings. Profiles and integration frameworks (such as those produced by implementer communities) combine technical formats with vocabulary constraints to reduce ambiguity across real deployments.
Regulatory backbone: 21st Century Cures, USCDI, TEFCA and QHIN participation
Policy and governance shape what must be shared and how trust is established between participants. Recent regulatory initiatives define minimum datasets, promote API access, discourage information blocking, and create national frameworks for trusted exchange. Those rules push organizations toward standardized APIs, common data elements, and participation in networks that provide authentication, consent and routing services. Compliance and participation in these frameworks are quickly becoming prerequisites for meaningful exchange at scale.
Understanding these technical layers, terminologies, and regulatory levers clarifies what success looks like: not a patchwork of point‑to‑point feeds, but an ecosystem where data is authentic, computable, and bounded by clear policy. With that in mind, the next section digs into why interoperability is the bottleneck for modern clinical priorities — from AI that needs standardized inputs to virtual care and value‑based programs that depend on reliable, shared outcomes data.
Why interoperability is the bottleneck for AI, telehealth, and value-based care
AI needs standardized, permissioned data: ambient scribing, autonomous EHR updates, admin automation
“Clinicians spend 45% of their time interacting with EHR systems. This heavy workload leads to 50% of workers burning out, and limited patient care time.” Healthcare Industry Challenges & AI-Powered Solutions — D-LAB research
“20% decrease in clinician time spend on EHR (News Medical Life Sciences). 30% decrease in after-hours working time (News Medical Life Sciences).” Healthcare Industry Challenges & AI-Powered Solutions — D-LAB research
Generative and assistive AI can only deliver the reductions in clinician burden described above if it consumes reliable, computable inputs and writes back in trusted ways. That means structured, normalized clinical data (labs, meds, problems), consistent vocabularies, auditable consent, and scoped write‑back APIs — not ad hoc document dumps. Without standardized, permissioned data flows, ambient scribing and autonomous EHR updates either produce noise (wrong mappings, duplicated orders) or create risk (incorrect updates, privacy violations). In short: models are powerful, but their clinical utility depends on predictable inputs, clear provenance, and enforceable access controls.
Virtual care at scale: telehealth + RPM streaming as FHIR Observations and Device data
“78% reduction in hospital admissions when COVID patients used Remote Patient Monitoring devices (Joshua C. Pritchett).” Healthcare Industry Challenges & AI-Powered Solutions — D-LAB research
“62% decrease in 6-month mortality rate for heart failure patients (Samantha Harris).” Healthcare Industry Challenges & AI-Powered Solutions — D-LAB research
Remote monitoring and telehealth deliver measurable outcomes, but only when device streams and visit records are integrated into longitudinal patient records and decision workflows. That requires consistent device models (so heart rate from vendor A means the same thing as from vendor B), time‑aligned observations, and event notifications that trigger clinical actions. FHIR Observation resources, device metadata standards, and subscription/event patterns are the mechanisms that let RPM become actionable rather than a flood of uninterpretable metrics.
Value-based care runs on shared outcomes, cost, and quality measures across EHR, payer, and registries
Value‑based payment models require common definitions of outcomes, cost attribution, and quality measures across multiple stakeholders. Payers, health systems, and registries must be able to compute the same measures from the same source data; otherwise reconciliation is manual, slow, and error‑prone. Interoperability at the semantic level (shared code systems and profiles) and timely exchange of claims, clinical, and outcome data are prerequisites to measure performance, automate reconciliation, and close financial and care loops.
Data quality layers: physical, syntactic, semantic, and provenance/governance
Interoperability failures are often data‑quality failures in disguise. Solve the physical layer (connectivity, device telemetry), and you still need syntactic correctness (well‑formed messages), semantic clarity (consistent codes, units, and value sets), and provenance/governance (who wrote this, when, under what consent). AI and analytics magnify garbage‑in problems: models trained on inconsistent or poorly labeled data amplify errors. Prioritizing these four layers — and instrumenting monitoring and feedback loops — is how organizations move from brittle integrations to reliable, scalable data platforms.
All of this shows why interoperability is not an optional IT project: it’s the foundational enabler for AI productivity, scalable virtual care, and accountable value‑based contracting. With those dependencies clear, the next logical step is a pragmatic roadmap: inventory, quick pilots, and trust controls that deliver measurable wins fast.
Build an actionable clinical interoperability roadmap
Start here: inventory systems, APIs, vocabularies, device interfaces, and data flows
Begin with a short, staffed discovery: catalog EHRs, ancillary systems (labs, imaging, devices), middleware, and any third‑party apps. For each item record the APIs exposed, data formats, owners, and current SLAs. Map the vocabularies in use (local codes vs. LOINC/SNOMED/RxNorm), identify device interfaces (serial, Bluetooth, vendor cloud), and draw the primary data flows that support clinical workflows. This inventory becomes the single source of truth for prioritization and risk assessment.
90-day wins: SMART on FHIR pilot, ADT event notifications, LOINC lab normalization
Select one high‑value, low‑risk pilot to prove the model. A SMART on FHIR app is a common quick win because it uses a standardized app‑to‑EHR launch and auth model (see SMART on FHIR: https://smarthealthit.org/). Implementing ADT (admit/discharge/transfer) event notifications stabilizes patient location awareness and routing; these are typically available via HL7 v2 / ADT feeds or FHIR subscription patterns (see HL7 v2 information: https://www.hl7.org/implement/standards/product_brief.cfm?product_id=185). Finally, normalizing incoming lab results to LOINC makes downstream alerts, decision support, and reporting reliable (LOINC: https://loinc.org/).
6–12 months: FHIR write APIs, Bulk Data/Flat FHIR, Subscriptions; TEFCA onboarding via a QHIN
After pilots, expand to two capability areas. First, enable controlled write APIs so validated apps and services can create or update discrete clinical data (use the HL7 FHIR API patterns: https://www.hl7.org/fhir/). Second, provision large exports and analytics with the FHIR Bulk Data specification (Flat FHIR / Bulk Data: https://hl7.org/fhir/uv/bulkdata/), and implement subscription/event patterns so clinical teams receive real‑time triggers (FHIR Subscriptions: https://www.hl7.org/fhir/subscriptions.html). If national trust frameworks are relevant, plan TEFCA participation or onboarding through an approved QHIN (see ONC TEFCA overview: https://www.healthit.gov/topic/interoperability/tefca).
Trust and safety: consent, OAuth2/OIDC, Zero Trust, auditing, and minimum necessary
Design the technical controls and policies in parallel with integration work. Use OAuth2 / OpenID Connect for authorization and delegated access (RFC 6749 and OpenID Connect: https://openid.net/specs/openid-connect-core-1_0.html), enforce role‑based scopes and “least privilege” principles, and adopt Zero Trust network controls (NIST SP 800‑207: https://csrc.nist.gov/publications/detail/sp/800-207/final). Implement auditable consent capture and retention policies and document “minimum necessary” access rules aligned with applicable privacy regulations (HHS guidance: https://www.hhs.gov/hipaa/for-professionals/privacy/guidance/minimum-necessary/index.html).
Proving value: track EHR time, after-hours work, no-shows, infusion errors, readmissions, denial rates
Define a small set of success metrics up front and instrument them for continuous measurement. Combine automated telemetry (API call volumes, subscription latencies, error rates) with operational KPIs tied to clinical value: clinician EHR time and after‑hours edits, appointment no‑show rates, medication/infusion error events, 30‑day readmissions, and claims denial rates. Use pre/post pilot baselines, set realistic targets, and report ROI in both clinical and financial terms at regular intervals.
Operationalizing interoperability is iterative: start with a focused pilot, shore up vocabularies and eventing, expand APIs and bulk export for analytics, and embed trust and measurement into every phase. With a clear roadmap and measurable milestones you turn standards and technologies into tangible improvements — and the next step is to apply these building blocks to concrete clinical use cases that deliver measurable ROI.
Thank you for reading Diligize’s blog!
Are you looking for strategic advise?
Subscribe to our newsletter!
Five clinical interoperability use cases with measurable ROI
Closed-loop medication safety: EMR–smart pump interoperability
Connect medication orders in the EHR to infusion pumps so prescriptions, dosing limits, and stop/titrate instructions are transmitted and confirmed electronically. A closed‑loop flow reduces manual transcription, prevents mismatched programming, and enforces dose‑checks at the bedside. Measure ROI by tracking medication programming errors, alarm overrides, adverse drug events, time spent on manual reconciliation, and the cost of corrective interventions. Key enablers are reliable eventing, consistent medication codings, and audited write‑back to the medical record.
Ambient documentation that writes structured Problems/Allergies/Orders via FHIR
Use ambient scribing and smart assistants to capture clinical encounters and convert them into discrete, coded Problems, Allergies, and Orders that are reviewable and approvable in the EHR. Interoperability ensures the extracted items map to controlled vocabularies and persist as structured data rather than free‑text notes. Track clinician time on charting, after‑hours documentation edits, note completeness, coding accuracy, and downstream effects like billing cycle time to quantify return on investment.
Telehealth + wearables: RPM streaming as FHIR Observations
Stream device and wearable telemetry into the clinical record as time‑stamped observations and device metadata so care teams can build longitudinal views and trigger workflows. Interoperable device models and subscription/event patterns let clinicians detect deterioration early, automate triage, and reduce unnecessary visits. Measure impact through utilisation metrics (admissions, ED visits), remote encounter volumes, alert fatigue rates, and patient adherence/engagement indicators.
Prior authorization automation with payer integration
Automate prior authorization exchanges between providers and payers using standardized clinical payloads and workflow APIs so requests include the necessary structured clinical evidence and decisions are routed and recorded automatically. Automation reduces back‑and‑forth, speeds determinations, and decreases clerical rework. Track authorization turnaround time, administrative hours per case, denial/appeal rates, and revenue leakage to demonstrate concrete savings.
EHR-to-research: FHIR‑to‑EDC for trial acceleration
Export curated, consented clinical data from the EHR into electronic data capture systems in a standardized format to avoid duplicate entry, speed cohort identification, and shorten study timelines. Interoperability that preserves provenance, timestamps, and mapping to study variables reduces queries and monitoring overhead. Measure ROI via enrollment speed, data entry effort saved, query resolution time, and trial cost per patient.
Each use case shares a repeatable structure: identify the clinical touchpoint, standardize the data model and vocabularies, implement secure eventing or APIs, and instrument outcome metrics before and after deployment. With clear metrics and a proven pilot, teams can move from point wins to organization‑wide programs — and the logical next step is to translate these use cases into procurement requirements, contract language, and implementation practices that ensure longevity and sustained value.
Procure and implement for longevity
Buy for standards, not custom feeds: contract for FHIR R4/R5 read/write, SMART, bulk export, and sandbox access
Write requirements into RFPs and contracts that mandate standards-first capabilities: FHIR REST APIs (current stable versions), SMART on FHIR app launch and OAuth patterns, and FHIR Bulk Data for large exports and analytics. Require vendor sandbox environments with representative test data and scripted onboarding support so integrations can be developed and validated without production risk. Specify API SLAs (availability, latency), documented error models, and clear export/exit clauses so you own patient data and can extract it on termination.
Sources: HL7 FHIR (https://hl7.org/fhir/), SMART on FHIR (https://smarthealthit.org/), FHIR Bulk Data (https://hl7.org/fhir/uv/bulkdata/).
Terminology operations: govern LOINC/SNOMED/RxNorm mapping and change control
Stand up a terminology operations function with technical, clinical, and informatics representation. Require vendors to support canonical code sets (LOINC, SNOMED CT, RxNorm) and to publish how their internal codes map to those standards. Put change control into contracts: scheduled terminology updates, impact assessments, test windows, and rollback mechanisms. Track provenance of mappings, and keep a living mapping registry that links source systems, transformation rules, and the business owner for each dataset.
Reference vocabularies: LOINC (https://loinc.org/), SNOMED International (https://www.snomed.org/), RxNorm (https://www.nlm.nih.gov/research/umls/rxnorm/).
Test like it matters: IHE-style workflows, synthetic data, negative and edge cases
Prioritize acceptance tests that mirror clinical workflows, not just API conformance. Use IHE integration profiles and end‑to‑end scenarios for key workflows (see IHE test materials) and require vendors to participate in plugfests or lab testing where possible. Build automated test suites that run against sandboxes and production‑like environments with synthetic patient data (e.g., Synthea) to validate happy paths, negative paths, race conditions, and edge cases such as out‑of‑order events, partial writes, and duplicate messages.
Helpful resources: IHE (https://www.ihe.net/), Synthea synthetic data (https://synthetichealth.github.io/).
Security and compliance: HIPAA, information blocking, audit trails, breach readiness
Embed security, privacy, and regulatory controls in procurement language. Require HIPAA‑compliant handling of protected health information and vendor attestations or certifications where appropriate (see HHS HIPAA guidance). Contractually require support for information‑blocking exceptions, full audit logging of data access and writes, timely breach notification procedures, and incident response playbooks. Include evidence‑based security requirements (encryption in transit and at rest, OAuth2/OIDC for delegated access, role‑based access controls, and logging retention policies) and require regular third‑party penetration testing and security attestations.
Regulatory guidance: HHS HIPAA overview (https://www.hhs.gov/hipaa/index.html), information blocking resources (https://www.healthit.gov/topic/information-blocking).
Future signals: TEFCA maturity, FHIR Subscriptions, imaging APIs, robotics/edge, genomics and nanomed data types
Design contracts and architecture with modularity and upgradeability so you can adopt emergent standards without rip‑and‑replace. Include optionality for participation in national trust frameworks, support for eventing/Subscriptions, and readiness for specialty APIs (imaging, genomics, device/edge telemetry). Require vendors to publish roadmaps and to agree to interoperability milestones tied to emerging standards, and include governance to evaluate and prioritize adoption based on clinical value.
Examples of standards to monitor: TEFCA/ONC resources (https://www.healthit.gov/topic/interoperability/tefca), FHIR Subscriptions (https://www.hl7.org/fhir/subscriptions.html), and DICOM/Imaging APIs (https://www.dicomstandard.org/).
Procurement and implementation done well treat interoperability as a product: owned by a team with clinical, technical, legal, and vendor‑management skills; specified in contracts; proven in test harnesses; and measured in live outcomes. That combination turns one‑off integrations into durable platforms that continue to deliver value as standards and care models evolve.